Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis

Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis

We present the case of a 79-year-old man who showed multiple pulmonary nodules on chest computed tomography (CT) after being treated for 6 months with ruxolitinib, an inhibitor of Janus kinase (JAK) 1 and 2, to treat primary myelofibrosis. We examined the lesions by bronchoscopy, and the biopsy spec...

Full description

Bibliographic Details
Main Authors: Anna Hirano, Masahiro Yamasaki, Naomi Saito, Koji Iwato, Wakako Daido, Kunihiko Funaishi, Sayaka Ishiyama, Naoko Deguchi, Masaya Taniwaki, Nobuyuki Ohashi
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Janus kinase inhibitor
Myelofibrosis
Pulmonary cryptococcosis
Pulmonary nodules
Ruxolitinib
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007117301740

Internet

http://www.sciencedirect.com/science/article/pii/S2213007117301740

Similar Items